Molecular Mechanism of Exercise in Cirrhosis

Recruiting N/A Interventional Study
Cirrhosis, Liver
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
40 (estimated)
Sponsor
The Cleveland Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to investigate the effects of 12 weeks of resistance or endurance exercise on patients with cirrhosis. Cirrhotic patients are prone to muscle loss (sarcopenia) and ammonia build up due to liver dysfunction. The liver which in healthy patients is able to process ammonia through ureagenesis is unable to do so in cirrhosis and ammonia is taken up either by the brain causing confusion …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion * Adult patients age 21-65 years of both genders * Diagnosis of cirrhosis by either liver biopsy, clinical, biochemical or imaging criteria * Child's score 5-10 * Model for End Stage Liver Disease (MELD) score less than 21 * Abstinence from alcohol and/or other recreational drugs for at l…
Contacts

Srinivasan Dasarathy, MD

216-318-7010

dasaras@ccf.org

CONTACT

Annette Bellar

bellara@ccf.org

CONTACT